Table 3.
Parameter | n = 386 | Overall survival since histological diagnosis |
|||
---|---|---|---|---|---|
Median (months) | P value | Hazard ratio | 95% CI | ||
Tumor volume | .002 | ||||
<100cc | 335 | 249 | 1 (ref) | ||
≥100cc | 51 | 142 | 2.31 | 1.27–3.96 | |
Spontaneous VDE | <.001 | ||||
<8 mm/year | 320 | 249 | 1 (ref) | ||
≥8 mm/year | 66 | 91 | 3.96 | 2.25–6.66 | |
Spontaneous VDE | <.001 | ||||
<4 mm/year | 196 | 253 | 1 (ref) | ||
4 and <8 mm/year | 126 | 210 | 1.33 | 0.59–1.50 | |
8 and <12 mm/year | 26 | 91 | 3.41 | 1.19–4.99 | |
12 and >mm/year | 40 | 75 | 5.91 | 2.28–8.82 | |
First-line surgical resection | .054 | ||||
No | 196 | 210 | 1 (ref) | ||
Yes | 190 | 249 | 0.74 | 0.47–1.15 | |
Parameter | n = 380 | Malignant free survival since histological diagnosis | |||
Corpus callosum involvement | .003 | ||||
No | 330 | 95 | 1 (ref) | ||
Yes | 50 | 59 | 1.73 | 1.16–2.50 | |
Contrast enhancement | .014 | ||||
No | 317 | 93 | 1 (ref) | ||
Faint and patchy | 51 | 89 | 1.46 | 1.11–1.88 | |
Nodular-like | 12 | 39 | 2.19 | 1.22–3.72 | |
Tumor volume | .001 | ||||
<100cc | 330 | 93 | 1 (ref) | ||
≥100cc | 50 | 48 | 1.90 | 1.26–2.76 | |
Spontaneous VDE | <.001 | ||||
<8 mm/year | 316 | 103 | 1 (ref) | ||
≥8 mm/year | 64 | 39 | 3.50 | 2.44–4.94 | |
Spontaneous VDE | <.001 | ||||
<4 mm/year | 195 | 117 | 1 (ref) | ||
4 and <8 mm/year | 123 | 83 | 1.43 | 0.78–1.91 | |
8 and <12 mm/year | 25 | 60 | 2.71 | 1.15–3.16 | |
12 and >mm/year | 39 | 31 | 6.50 | 3.23–7.92 | |
First-line surgical resection | <.001 | ||||
No | 192 | 68 | 1 (ref) | ||
Yes | 188 | 127 | 0.42 | 0.31–0.57 | |
Extent of surgical resection | <.001 | ||||
Biopsy | 192 | 68 | 1 (ref) | ||
Partial removal | 86 | 103 | 0.59 | 0.22–0.96 | |
Subtotal removal | 64 | 133 | 0.39 | 0.14–0.78 | |
Total removal | 38 | . | 0.09 | 0.003–0.17 |